[Dipotassium chlorazepate in chronic itching dermatoses--especially in atopic constitutional neurodermitis].
D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001007:Anxiety; D003009:Clorazepate Dipotassium / Q000627:therapeutic use*; D003863:Depression / Q000150:complications; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D006801:Humans; D009450:Neurodermatitis / Q000188:drug therapy* / Q000209:etiology; D010919:Placebos; D011537:Pruritus / Q000188:drug therapy*; D012893:Sleep Wake Disorders / Q000150:complications / Q000188:drug therapy; D014149:Tranquilizing Agents / Q000627:therapeutic use
D014151:Anti-Anxiety Agents; D010919:Placebos; D014149:Tranquilizing Agents; D003009:Clorazepate Dipotassium
Dikalium-chlorazepat bei chronisch juckenden Dermatosen-insbesondere bei atopischer konstitutioneller Neurodermitis